Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 186

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 186
---
— 3,902 Corporate securities— 14,532 46 14,578 Residential mortgage-backed securities— 3,830 2 3,832 Commercial mortgage-backed securities— 2,047 — 2,047 Other asset-backed securities— 3,634 539 4,173 Total fixed maturity securities, available-for-sale— 29,903 587 30,490 Equity securities:Exchange traded funds106 — — 106 Common equity securities12 33 — 45 Private equity securities— — 78 78 Total equity securities118 33 78 229 Other invested assets - common equity securities111 — — 111 Securities lending collateral— 2,382 — 2,382 Derivatives - other assets— 10 — 10 Total assets$2,439 $32,328 $665 $35,432 Liabilities:Derivatives - other liabilities$— $(40)$— $(40)Total liabilities$— $(40)$— $(40)A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the years ended December 31, 2024, 2023 and 2022 is as follows:

 -99-

Elevance Health, Inc.Notes to Consolidated Financial Statements (continued)

CorporateSecuritiesResidentialMortgage-backedSecuritiesOther Asset-Backed SecuritiesEquitySecuritiesTotalYear ended December 31, 2024Beginning balance at January 1, 2024$46 $2 $539 $78 $665 Total gains (losses):Recognized in net income1 — — (6)(5)Recognized in accumulated other comprehensive income— — 12 — 12 Purchases26 10 118 17 171 Sales(5)(2)(10)(17)(34)Settlements(4)— (1)— (5)Transfers into Level III— — 92 — 92 Transfers out of Level III(21)— (3)— (24)Ending balance at December 31, 2024$43 $10 $747 $72 $872 Change in unrealized gains or losses included in net income related to assets still held at December 31, 2024